Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - pethidine hydrochloride -

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - pethidine hydrochloride 50 mg/ml; pethidine hydrochloride 50 mg/ml - solution for injection - 50 mg/ml - active: pethidine hydrochloride 50 mg/ml excipient: water for injection active: pethidine hydrochloride 50 mg/ml excipient: sodium hydroxide water for injection - dbl pethidine hydrochloride injection is indicated for administration as an anaesthetic adjunct and for obstetric analgesia. dbl pethidine hydrochloride injection is also indicated for the short-term (24 to 36 hours) management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. it can be given via the following routes of administration – intramuscular (im), subcutaneous (sc), slow intravenous (iv) bolus injection, intravenous infusion and patient-controlled analgesia (pca).

New Zealand - English - Medsafe (Medicines Safety Authority)

max health limited - pethidine hydrochloride 50 mg/ml - solution for injection - 5% w/v - active: pethidine hydrochloride 50 mg/ml excipient: sodium hydroxide water for injection - pethidine is indicated for short-term (24-36 hours) relief of moderate to severe pain. it can be given via the following routes of administration - intramuscular, subcutaneous, slow intravenous bolus injection, intravenous infusion and patient controlled analgesia (pca).